These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7198948)

  • 41. Biochemical and mitogenic properties of Tamm-Horsfall urinary glycoprotein.
    Hunt JS; MacDonald PR; Day WA; McGiven AR
    Pathology; 1980 Oct; 12(4):609-21. PubMed ID: 7465256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of Tamm-Horsfall protein and uromodulin in calcium oxalate crystallization.
    Carvalho M; Mulinari RA; Nakagawa Y
    Braz J Med Biol Res; 2002 Oct; 35(10):1165-72. PubMed ID: 12424489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary Tamm-Horsfall glycoprotein in patients with various renal diseases.
    Nakagawa Y
    Nihon Jinzo Gakkai Shi; 1987 May; 29(5):529-34. PubMed ID: 3656710
    [No Abstract]   [Full Text] [Related]  

  • 44. Tamm Horsfall Glycoprotein and Uromodulin: It Is All about the Tubules!
    Bleyer AJ; Kmoch S
    Clin J Am Soc Nephrol; 2016 Jan; 11(1):6-8. PubMed ID: 26683889
    [No Abstract]   [Full Text] [Related]  

  • 45. Problems relating to the storage and treatment of urine samples before radioimmunoassay for Tamm-Horsfall glycoprotein.
    Goodall AA; Marshall RD
    Biochem Soc Trans; 1978; 6(5):1043-7. PubMed ID: 744317
    [No Abstract]   [Full Text] [Related]  

  • 46. A new ELISA method for the rapid quantification of Tamm-Horsfall protein in urine.
    Reinhart HH; Obedeanu N; Walz D; Sobel JD
    Am J Clin Pathol; 1989 Aug; 92(2):199-205. PubMed ID: 2756935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary excretion of Tamm-Horsfall protein in normotensive, normo-albuminuric type 1 diabetic patients.
    Catalano C; Torffvit O
    Nephron; 1996; 72(3):436-41. PubMed ID: 8852493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcium oxalate stone agglomeration reflects stone-forming activity: citrate inhibition depends on macromolecules larger than 30 kilodalton.
    Erwin DT; Kok DJ; Alam J; Vaughn J; Coker O; Carriere BT; Lindberg J; Husserl FE; Fuselier H; Cole FE
    Am J Kidney Dis; 1994 Dec; 24(6):893-900. PubMed ID: 7985666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased urinary levels of Tamm-Horsfall glycoprotein suggest a systemic etiology of interstitial cystitis.
    Bade JJ; Marrink J; Karrenbeld A; van der Weele L; Mensink HJ
    J Urol; 1996 Sep; 156(3):943-6. PubMed ID: 8709369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patients with recurrent renal stones have a physico-chemically altered urinary Tamm-Horsfall glycoprotein profile.
    Jefferson A; Reynolds TM; Elves A; Wierzbicki AS
    Ann Clin Biochem; 1996 Nov; 33 ( Pt 6)():540-4. PubMed ID: 8937586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-mannose oligosaccharides from human Tamm-Horsfall glycoprotein.
    Serafini-Cessi F; Dall'Olio F; Malagolini N
    Biosci Rep; 1984 Mar; 4(3):269-74. PubMed ID: 6722291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variations of urinary Tamm-Horsfall protein in humans during the first thirty years of life.
    Ollier-Hartmann MP; Pouget-Abadie C; Bouillie J; Hartmann L
    Nephron; 1984; 38(3):163-6. PubMed ID: 6436719
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Properties of a glycopeptide isolated from human Tamm-Horsfall glycoprotein. Interaction with leucoagglutinin and anti-(human Tamm-Horsfall glycoprotein) antibodies.
    Abbondanza A; Franceschi C; Licastro F; Serafini-Cessi F
    Biochem J; 1980 May; 187(2):525-8. PubMed ID: 6967312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers.
    Fuselier HA; Ward DM; Lindberg JS; Allen JM; Husserl FE; Marcucci PA; Cole FE; Turnipseed J; Alam J; Kok DJ
    Urology; 1995 Jun; 45(6):942-6. PubMed ID: 7771027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Juvenile renal stone disease: a study of urinary promoting and inhibiting factors.
    Baggio B; Gambaro G; Favaro S; Borsatti A; Pavanello L; Siviero B; Zacchello G; Rizzoni GF
    J Urol; 1983 Dec; 130(6):1133-5. PubMed ID: 6315967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tamm-Horsfall protein excretion and its relation to citrate in urine of stone-forming patients.
    Ganter K; Bongartz D; Hesse A
    Urology; 1999 Mar; 53(3):492-5. PubMed ID: 10096372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function.
    Jaggi M; Nakagawa Y; Zipperle L; Hess B
    Urol Res; 2007 Apr; 35(2):55-62. PubMed ID: 17345077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical significance of determination of urinary albumin, beta 2 microglobulin and Tamm-Horsfall protein in diabetics].
    Yu M; Zhu YQ
    Zhonghua Nei Ke Za Zhi; 1991 Jun; 30(6):354-6, 383. PubMed ID: 1914672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of human uromodulin as the Tamm-Horsfall urinary glycoprotein.
    Pennica D; Kohr WJ; Kuang WJ; Glaister D; Aggarwal BB; Chen EY; Goeddel DV
    Science; 1987 Apr; 236(4797):83-8. PubMed ID: 3453112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Excretion of urinary casts after the administration of diuretics.
    Imhof PR; Hushak J; Schumann G; Dukor P; Wagner J; Keller HM
    Br Med J; 1972 Apr; 2(5807):199-202. PubMed ID: 4553942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.